Quote & Headlines
StockTalk
IMCL is defunct.
FOCUS
|
PRO
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
ImClone Jumps on Lung Cancer ResultsRoy Mehta • Tue, Sep 11, 2007
-
ImClone Shares Tumble on Rumors of Cancer Drug ShortfallSA Editor Eli Hoffmann • Wed, May 16, 2007
-
Icahn Hopes to 'Get Lucky Again' with ImCloneSteven Towns • Thu, Oct 26, 2006
-
ImClone Systems: Will It Benefit From a Dose of Carl Icahn?10Q Detective • Mon, Sep 25, 2006
-
Carl Icahn Asks Imclone Chairman To Step DownLon Juricic • Thu, Sep 21, 2006
To learn more about Seeking Alpha Pro, click here.
-
VC Financings Boost Interest in BiotechThe Burrill Report • Fri, Jul 24, 2009
-
Hedge Fund Portfolio Tracking: SAC Capital (Steven Cohen), Q3 2008Market Folly • Thu, Jan 15, 2009
-
Biotech ETFs a Rare Safe HavenTom Lydon • Fri, Nov 14, 2008
-
Four Thoughts on the Imclone/Lilly DealDerek Lowe • Tue, Oct 7, 2008
-
Discovery Labs: The Next Biotech Buy?Mike Havrilla • Mon, Oct 6, 2008
-
ImClone Systems, Inc. Q1 2008 Earnings Call TranscriptTue, Apr 29, 2008
-
ImClone Systems, Inc. Q1 2008 Earnings Call TranscriptFri, Apr 25, 2008 • 3 Comments
-
ImClone Systems Inc. Q4 2007 Earnings Call TranscriptMon, Feb 4, 2008
-
ImClone Systems Inc. Q3 2007 Earnings Call TranscriptFri, Oct 26, 2007
-
at CNBC.com (Nov 23, 2010)
Company Description
We are a biopharmaceutical company whose mission is to advance oncology care by developing and commercializing a portfolio of targeted treatments designed to address the medical needs of patients with cancer. We focus on what we believe are two promising strategies for treating cancer: growth... More
Country: United States
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.